Luc Marengere - Net Worth and Insider Trading
Luc Marengere Net Worth
The estimated net worth of Luc Marengere is at least $70 Million dollars as of 2024-12-28. Luc Marengere is the Director, 10% Owner of CoLucid Pharmaceuticals Inc and owns about 1,495,386 shares of CoLucid Pharmaceuticals Inc (CLCD) stock worth over $70 Million. Details can be seen in Luc Marengere's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Luc Marengere has not made any transactions after 2015-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Luc Marengere
Luc Marengere Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Luc Marengere owns 2 companies in total, including Acer Therapeutics Inc (ACER) , and CoLucid Pharmaceuticals Inc (CLCD) .
Click here to see the complete history of Luc Marengere’s form 4 insider trades.
Insider Ownership Summary of Luc Marengere
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ACER | Acer Therapeutics Inc | 2017-09-19 | director & 10 percent owner |
CLCD | CoLucid Pharmaceuticals Inc | 2017-03-01 | director & 10 percent owner |
Luc Marengere Latest Holdings Summary
Luc Marengere currently owns a total of 1 stock. Luc Marengere owns 1,495,386 shares of CoLucid Pharmaceuticals Inc (CLCD) as of May 11, 2015, with a value of $70 Million.
Latest Holdings of Luc Marengere
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CLCD | CoLucid Pharmaceuticals Inc | 2015-05-11 | 1,495,386 | 46.53 | 69,572,834 |
Holding Weightings of Luc Marengere
Luc Marengere Form 4 Trading Tracker
According to the SEC Form 4 filings, Luc Marengere has made a total of 0 transactions in CoLucid Pharmaceuticals Inc (CLCD) over the past 5 years. The most-recent trade in CoLucid Pharmaceuticals Inc is the acquisition of 500,000 shares on May 11, 2015, which cost Luc Marengere around $5 Million.
Insider Trading History of Luc Marengere
- 1
Luc Marengere Trading Performance
GuruFocus tracks the stock performance after each of Luc Marengere's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Luc Marengere is -5.01%. GuruFocus also compares Luc Marengere's trading performance to market benchmark return within the same time period. The performance of stocks bought by Luc Marengere within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Luc Marengere's insider trading performs compared to the benchmark.
Performance of Luc Marengere
Luc Marengere Ownership Network
Luc Marengere Owned Company Details
What does Acer Therapeutics Inc do?
Who are the key executives at Acer Therapeutics Inc?
Luc Marengere is the director & 10 percent owner of Acer Therapeutics Inc. Other key executives at Acer Therapeutics Inc include director & President and Chief Executive Chris Schelling , Chief Operating Officer Tanya Hayden , and Chief Medical Officer Adrian W Quartel .
Acer Therapeutics Inc (ACER) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acer Therapeutics Inc (ACER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acer Therapeutics Inc (ACER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acer Therapeutics Inc (ACER)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acer Therapeutics Inc Insider Transactions
Luc Marengere Mailing Address
Above is the net worth, insider trading, and ownership report for Luc Marengere. You might contact Luc Marengere via mailing address: 15 New England Executive Park, Burlington Ma 01803.